Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaNutra is an Italian pharmaceutical company specializing in the development of nutraceutical supplements and medical devices, most notably through its Cetilar and SiderAL brand lines. The company is recognized for its proprietary Sucrosomial Technology, which enhances the absorption and bioavailability of minerals like iron, and its use of cetylated fatty acids (CFA) for joint and muscle recovery. Athletica Cetilar is the company's dedicated sports division and community, focusing on the application of its topical treatments and supplements within professional and amateur athletics. PharmaNutra operates a vertically integrated model encompassing R&D, production, and commercialization of products targeting iron deficiency, bone health, and sports medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Athletica Cetilar.